Search

Showing total 1,831 results

Search Constraints

Start Over You searched for: Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years Journal alimentary pharmacology & therapeutics Remove constraint Journal: alimentary pharmacology & therapeutics Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
1,831 results

Search Results

1. Monitoring disease progression in metabolic dysfunction‐associated steatotic liver disease.

2. Systematic review: Clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers.

3. Letter: Association of persistently high HBsAg levels during HBeAg‐seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients—Authors' reply.

4. Editorial: Hepatitis C virus eradication improves skeletal muscle mass—Authors' reply.

5. Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma.

7. A Message from the Editors.

8. Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus‐related hepatocellular carcinoma after curative hepatectomy.

9. Practical considerations for fluid resuscitation in cirrhosis.

10. Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD—Authors' reply.

11. Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD.

12. Editorial: Mortality in immune‐mediated inflammatory diseases during early adulthood—Authors' reply.

16. Letter: The enigma of angiotensin receptor blocker‐associated enteropathy—Authors' reply.

18. Letter: Potential confounders might exaggerate the risk of rheumatoid arthritis in patients with microscopic colitis.

23. Editorial: High qHBsAg—is it a good or bad signal?

25. Letter: The enigma of angiotensin receptor blocker‐associated enteropathy.

26. Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma. Authors' reply.

28. Editorial: Exploring the influence of diet on later‐onset ulcerative colitis—Are eggs and spicy foods the key factors in Asia? Authors' reply.

31. Letter: Association of persistently high HBsAg levels during HBeAg‐seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients.

35. Letter: Shorter duration of intravenous terlipressin for variceal bleeding in patients with cirrhosis—A promising find.

38. Letter: Shorter duration of intravenous terlipressin for variceal bleeding in patients with cirrhosis—A promising find. Author's reply.

42. Editorial: Are glucagon‐like peptide‐1 receptor agonists the functional cure for patients with metabolic dysfunction‐associated cirrhosis?

45. Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply.

46. Letter: The emerging role of novel capsule endoscopy systems in gastroenterology with specific reference to small bowel Crohn's disease. Authors' reply.

48. Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D—Authors' reply.

49. Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms—still a long way to go... Authors' reply'.